DG INNOVATE PLC Logo

DG INNOVATE PLC

Develops sustainable technologies for electric mobility and energy storage solutions.

DGI | IL

Overview

Corporate Details

ISIN(s):
GB00BMZ3D204 (+2 more)
LEI:
21380058VQBP76M7TN11
Country:
United Kingdom
Address:
15 VICTORIA MEWS COTTINGLEY BUSINESS PARK, BD16 1PY BINGLEY

Description

DG Innovate PLC is an advanced research and development company pioneering sustainable and environmentally considerate technologies for electric mobility and energy storage. The company focuses on developing proprietary solutions, including ultra-high performance electric drive systems and advanced energy storage materials. Its key product portfolio features the Pareta® e-drive, a novel motor technology designed for electric vehicles. DG Innovate's work targets the sustainable transportation and energy sectors, leveraging its expertise in material science and electric motor innovation to create next-generation solutions.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2024-09-16 10:27
Retail Offer for up to £100,000
English HTML 39.7 KB
2024-09-16 10:22
Proposed Fundraising & Business Update
English HTML 73.2 KB
2024-09-11 13:50
Holding(s) in Company
English HTML 22.0 KB
2024-08-29 08:00
Board Changes
English HTML 14.0 KB
2024-07-19 11:36
DG Innovate Delivers Pareta® Motor Prototype
English HTML 12.2 KB
2024-07-09 08:00
Appointment of Non-Executive Director
English HTML 15.6 KB
2024-07-02 19:26
Result of AGM and Corporate Update
English HTML 37.5 KB
2024-06-21 08:00
Appointment of Non-Executive Director
English HTML 16.4 KB
2024-06-12 08:00
Appointment of Chief Technical Officer
English HTML 15.5 KB
2024-06-10 08:00
Directorate Change and Notice of AGM
English HTML 14.5 KB
2024-05-31 08:00
Total Voting Rights
English HTML 13.3 KB
2024-05-14 14:50
Holding(s) in Company
English HTML 22.0 KB
2024-05-13 15:18
Block Listing Return & Block Listing Cancellation
English HTML 24.2 KB
2024-05-09 08:00
Placing to raise £786,500
English HTML 37.1 KB
2024-05-03 08:00
Ex-Tesla electric motor design engineer appointed
English HTML 15.2 KB

Automate Your Workflow. Get a real-time feed of all DG INNOVATE PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for DG INNOVATE PLC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for DG INNOVATE PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
Biotechnology company providing R&D and services for the life sciences sector.
Spain
IKM
2cureX AB Logo
Develops an IVD test using 3D tumoroids to predict patient response to cancer drugs.
Sweden
2CUREX
Abera Bioscience AB Logo
Develops mucosal vaccines using a proprietary Outer Membrane Vesicle (OMV) platform.
Sweden
ABERA
Clinical-stage biopharma developing therapeutics for oncology and viral diseases.
South Korea
203400
ABL Bio Inc. Logo
Develops bispecific antibody therapeutics for oncology and neurodegenerative diseases.
South Korea
298380
Abpro Holdings, Inc. Logo
Clinical-stage biotech developing antibody therapeutics for oncology and ophthalmology.
United States of America
ABP
Absci Corp Logo
A generative AI drug creation company developing biologic medicines.
United States of America
ABSI
Achiko AG Logo
A digital services platform for cross-border business compliance and engagement.
Switzerland
ACHI
Active Biotech Logo
Biotechnology company developing drugs for oncology and inflammatory eye disorders.
Sweden
ACTI
Adagene Inc. Logo
Clinical-stage biotech developing antibody-based immunotherapies for oncology.
United States of America
ADAG

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.